nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—F2—hepatic artery—gallbladder cancer	0.198	0.21	CbGeAlD
Menadione—F2—portal vein—gallbladder cancer	0.172	0.182	CbGeAlD
Menadione—PROZ—liver—gallbladder cancer	0.0423	0.0448	CbGeAlD
Menadione—F9—epithelium—gallbladder cancer	0.0403	0.0427	CbGeAlD
Menadione—F2—gall bladder—gallbladder cancer	0.0296	0.0313	CbGeAlD
Menadione—PROC—liver—gallbladder cancer	0.0273	0.0288	CbGeAlD
Menadione—NQO1—gall bladder—gallbladder cancer	0.0247	0.0261	CbGeAlD
Menadione—F7—liver—gallbladder cancer	0.0239	0.0253	CbGeAlD
Menadione—F9—liver—gallbladder cancer	0.0228	0.0242	CbGeAlD
Menadione—AOX1—gall bladder—gallbladder cancer	0.0226	0.024	CbGeAlD
Menadione—VKORC1L1—liver—gallbladder cancer	0.0225	0.0238	CbGeAlD
Menadione—PROS1—pancreas—gallbladder cancer	0.0203	0.0215	CbGeAlD
Menadione—VKORC1—pancreas—gallbladder cancer	0.0183	0.0194	CbGeAlD
Menadione—VKORC1L1—lymph node—gallbladder cancer	0.0173	0.0183	CbGeAlD
Menadione—F2—epithelium—gallbladder cancer	0.0153	0.0162	CbGeAlD
Menadione—GGCX—liver—gallbladder cancer	0.0136	0.0144	CbGeAlD
Menadione—NQO2—pancreas—gallbladder cancer	0.0136	0.0144	CbGeAlD
Menadione—PROS1—liver—gallbladder cancer	0.0129	0.0137	CbGeAlD
Menadione—NQO1—epithelium—gallbladder cancer	0.0128	0.0135	CbGeAlD
Menadione—F10—liver—gallbladder cancer	0.0122	0.0129	CbGeAlD
Menadione—VKORC1—liver—gallbladder cancer	0.0117	0.0124	CbGeAlD
Menadione—NQO1—pancreas—gallbladder cancer	0.0114	0.012	CbGeAlD
Menadione—NQO1—Transcriptional activation by NRF2—KEAP1—gallbladder cancer	0.0112	0.204	CbGpPWpGaD
Menadione—XDH—liver—gallbladder cancer	0.0104	0.0111	CbGeAlD
Menadione—GGCX—lymph node—gallbladder cancer	0.0104	0.0111	CbGeAlD
Menadione—AOX1—pancreas—gallbladder cancer	0.0104	0.011	CbGeAlD
Menadione—PROS1—lymph node—gallbladder cancer	0.00992	0.0105	CbGeAlD
Menadione—F10—lymph node—gallbladder cancer	0.00934	0.00988	CbGeAlD
Menadione—VKORC1—lymph node—gallbladder cancer	0.00895	0.00947	CbGeAlD
Menadione—MTHFR—liver—gallbladder cancer	0.00868	0.00918	CbGeAlD
Menadione—F2—liver—gallbladder cancer	0.00868	0.00918	CbGeAlD
Menadione—NQO2—liver—gallbladder cancer	0.00864	0.00915	CbGeAlD
Menadione—NQO1—liver—gallbladder cancer	0.00724	0.00766	CbGeAlD
Menadione—CYP2A6—liver—gallbladder cancer	0.00693	0.00734	CbGeAlD
Menadione—MTHFR—lymph node—gallbladder cancer	0.00665	0.00704	CbGeAlD
Menadione—AOX1—liver—gallbladder cancer	0.00664	0.00703	CbGeAlD
Menadione—NQO2—lymph node—gallbladder cancer	0.00663	0.00701	CbGeAlD
Menadione—MAOB—Alpha-synuclein signaling—UCHL1—gallbladder cancer	0.00655	0.119	CbGpPWpGaD
Menadione—CYP1A1—epithelium—gallbladder cancer	0.00634	0.00671	CbGeAlD
Menadione—NQO1—lymph node—gallbladder cancer	0.00555	0.00587	CbGeAlD
Menadione—MAOB—liver—gallbladder cancer	0.00512	0.00541	CbGeAlD
Menadione—AOX1—lymph node—gallbladder cancer	0.00509	0.00539	CbGeAlD
Menadione—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—KEAP1—gallbladder cancer	0.00422	0.0768	CbGpPWpGaD
Menadione—MAOB—lymph node—gallbladder cancer	0.00392	0.00415	CbGeAlD
Menadione—CYP1A2—liver—gallbladder cancer	0.00364	0.00385	CbGeAlD
Menadione—CYP1A1—liver—gallbladder cancer	0.00359	0.0038	CbGeAlD
Menadione—CYP2E1—liver—gallbladder cancer	0.00328	0.00347	CbGeAlD
Menadione—CYP1A1—lymph node—gallbladder cancer	0.00275	0.00291	CbGeAlD
Menadione—BGLAP—Interleukin-11 Signaling Pathway—BCL2—gallbladder cancer	0.0023	0.0419	CbGpPWpGaD
Menadione—NQO1—NRF2 pathway—KEAP1—gallbladder cancer	0.00181	0.033	CbGpPWpGaD
Menadione—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—ERBB3—gallbladder cancer	0.00168	0.0305	CbGpPWpGaD
Menadione—BGLAP—Interleukin-11 Signaling Pathway—HRAS—gallbladder cancer	0.00125	0.0227	CbGpPWpGaD
Menadione—F7—Folate Metabolism—TP53—gallbladder cancer	0.001	0.0182	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.000895	0.0163	CbGpPWpGaD
Menadione—MTHFR—Fluoropyrimidine Activity—TP53—gallbladder cancer	0.000882	0.0161	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.000815	0.0148	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.000815	0.0148	CbGpPWpGaD
Menadione—PROC—Cell surface interactions at the vascular wall—NRAS—gallbladder cancer	0.000794	0.0144	CbGpPWpGaD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—TP53—gallbladder cancer	0.000792	0.0144	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00077	0.014	CbGpPWpGaD
Menadione—CYP2A6—NRF2 pathway—KEAP1—gallbladder cancer	0.00072	0.0131	CbGpPWpGaD
Menadione—PROS1—Cell surface interactions at the vascular wall—NRAS—gallbladder cancer	0.000702	0.0128	CbGpPWpGaD
Menadione—PROC—Cell surface interactions at the vascular wall—KRAS—gallbladder cancer	0.000683	0.0124	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.000655	0.0119	CbGpPWpGaD
Menadione—PROS1—Cell surface interactions at the vascular wall—KRAS—gallbladder cancer	0.000604	0.011	CbGpPWpGaD
Menadione—PROC—Cell surface interactions at the vascular wall—HRAS—gallbladder cancer	0.000581	0.0106	CbGpPWpGaD
Menadione—PROS1—Cell surface interactions at the vascular wall—HRAS—gallbladder cancer	0.000514	0.00935	CbGpPWpGaD
Menadione—PROS1—Immune System—KEAP1—gallbladder cancer	0.00051	0.00927	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—TP53—gallbladder cancer	0.000507	0.00922	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—ERBB4—gallbladder cancer	0.000416	0.00756	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—TP53—gallbladder cancer	0.000411	0.00748	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—ERBB3—gallbladder cancer	0.000359	0.00654	CbGpPWpGaD
Menadione—CYP2A6—Fluoropyrimidine Activity—TP53—gallbladder cancer	0.000355	0.00645	CbGpPWpGaD
Menadione—F2—Folate Metabolism—TP53—gallbladder cancer	0.000349	0.00634	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—NRAS—gallbladder cancer	0.00033	0.006	CbGpPWpGaD
Menadione—F9—Hemostasis—NRAS—gallbladder cancer	0.000292	0.00532	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—KRAS—gallbladder cancer	0.000284	0.00516	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.000265	0.00482	CbGpPWpGaD
Menadione—F7—Hemostasis—NRAS—gallbladder cancer	0.000257	0.00467	CbGpPWpGaD
Menadione—F9—Hemostasis—KRAS—gallbladder cancer	0.000252	0.00458	CbGpPWpGaD
Menadione—PROS1—Immune System—ERBB4—gallbladder cancer	0.000242	0.00441	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.000241	0.00439	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.000241	0.00439	CbGpPWpGaD
Menadione—F2—Cell surface interactions at the vascular wall—HRAS—gallbladder cancer	0.000241	0.00439	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—NRAS—gallbladder cancer	0.000238	0.00432	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—BCL2—gallbladder cancer	0.000232	0.00422	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.000228	0.00415	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—ERBB2—gallbladder cancer	0.000225	0.0041	CbGpPWpGaD
Menadione—F9—Hemostasis—TP53—gallbladder cancer	0.000224	0.00407	CbGpPWpGaD
Menadione—F7—Hemostasis—KRAS—gallbladder cancer	0.000221	0.00402	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—EGFR—gallbladder cancer	0.000216	0.00394	CbGpPWpGaD
Menadione—PROC—Hemostasis—NRAS—gallbladder cancer	0.000215	0.00392	CbGpPWpGaD
Menadione—F9—Hemostasis—HRAS—gallbladder cancer	0.000214	0.00389	CbGpPWpGaD
Menadione—PROS1—Immune System—ERBB3—gallbladder cancer	0.000209	0.00381	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—KRAS—gallbladder cancer	0.000204	0.00372	CbGpPWpGaD
Menadione—F7—Hemostasis—TP53—gallbladder cancer	0.000196	0.00357	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.000194	0.00353	CbGpPWpGaD
Menadione—PROS1—Hemostasis—NRAS—gallbladder cancer	0.00019	0.00347	CbGpPWpGaD
Menadione—F7—Hemostasis—HRAS—gallbladder cancer	0.000188	0.00342	CbGpPWpGaD
Menadione—PROC—Hemostasis—KRAS—gallbladder cancer	0.000185	0.00337	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.000177	0.00322	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—NRAS—gallbladder cancer	0.000171	0.00312	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.000169	0.00307	CbGpPWpGaD
Menadione—PROC—Hemostasis—TP53—gallbladder cancer	0.000165	0.003	CbGpPWpGaD
Menadione—PROS1—Hemostasis—KRAS—gallbladder cancer	0.000164	0.00298	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.000161	0.00294	CbGpPWpGaD
Menadione—PROC—Hemostasis—HRAS—gallbladder cancer	0.000157	0.00286	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—EGFR—gallbladder cancer	0.000156	0.00284	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.000154	0.0028	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.000154	0.0028	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000152	0.00278	CbGpPWpGaD
Menadione—MTHFR—Disease—ERBB4—gallbladder cancer	0.000152	0.00277	CbGpPWpGaD
Menadione—AOX1—Disease—ERBB4—gallbladder cancer	0.000149	0.00271	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—KRAS—gallbladder cancer	0.000148	0.00268	CbGpPWpGaD
Menadione—PROS1—Hemostasis—TP53—gallbladder cancer	0.000146	0.00265	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.000145	0.00264	CbGpPWpGaD
Menadione—F10—Hemostasis—NRAS—gallbladder cancer	0.000145	0.00264	CbGpPWpGaD
Menadione—PROS1—Hemostasis—HRAS—gallbladder cancer	0.000139	0.00253	CbGpPWpGaD
Menadione—PROS1—Immune System—BCL2—gallbladder cancer	0.000135	0.00246	CbGpPWpGaD
Menadione—MTHFR—Disease—ERBB3—gallbladder cancer	0.000132	0.0024	CbGpPWpGaD
Menadione—PROS1—Immune System—ERBB2—gallbladder cancer	0.000131	0.00239	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.00013	0.00236	CbGpPWpGaD
Menadione—AOX1—Disease—ERBB3—gallbladder cancer	0.000129	0.00234	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—HRAS—gallbladder cancer	0.000125	0.00228	CbGpPWpGaD
Menadione—F10—Hemostasis—KRAS—gallbladder cancer	0.000125	0.00227	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.000124	0.00225	CbGpPWpGaD
Menadione—F10—Hemostasis—TP53—gallbladder cancer	0.000111	0.00202	CbGpPWpGaD
Menadione—F10—Hemostasis—HRAS—gallbladder cancer	0.000106	0.00193	CbGpPWpGaD
Menadione—PROS1—Immune System—NRAS—gallbladder cancer	9.98e-05	0.00182	CbGpPWpGaD
Menadione—PROS1—Immune System—EGFR—gallbladder cancer	9.1e-05	0.00166	CbGpPWpGaD
Menadione—F2—Hemostasis—NRAS—gallbladder cancer	8.93e-05	0.00163	CbGpPWpGaD
Menadione—PROS1—Immune System—KRAS—gallbladder cancer	8.59e-05	0.00156	CbGpPWpGaD
Menadione—MTHFR—Disease—ERBB2—gallbladder cancer	8.26e-05	0.0015	CbGpPWpGaD
Menadione—AOX1—Disease—ERBB2—gallbladder cancer	8.07e-05	0.00147	CbGpPWpGaD
Menadione—F2—Hemostasis—KRAS—gallbladder cancer	7.69e-05	0.0014	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ERBB4—gallbladder cancer	7.34e-05	0.00134	CbGpPWpGaD
Menadione—PROS1—Immune System—HRAS—gallbladder cancer	7.3e-05	0.00133	CbGpPWpGaD
Menadione—F2—Hemostasis—TP53—gallbladder cancer	6.83e-05	0.00124	CbGpPWpGaD
Menadione—F2—Hemostasis—HRAS—gallbladder cancer	6.54e-05	0.00119	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ERBB3—gallbladder cancer	6.35e-05	0.00116	CbGpPWpGaD
Menadione—MTHFR—Disease—NRAS—gallbladder cancer	6.29e-05	0.00114	CbGpPWpGaD
Menadione—AOX1—Disease—NRAS—gallbladder cancer	6.14e-05	0.00112	CbGpPWpGaD
Menadione—MTHFR—Disease—EGFR—gallbladder cancer	5.73e-05	0.00104	CbGpPWpGaD
Menadione—AOX1—Disease—EGFR—gallbladder cancer	5.59e-05	0.00102	CbGpPWpGaD
Menadione—MTHFR—Disease—KRAS—gallbladder cancer	5.41e-05	0.000984	CbGpPWpGaD
Menadione—AOX1—Disease—KRAS—gallbladder cancer	5.28e-05	0.000962	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—NRAS—gallbladder cancer	5.13e-05	0.000933	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—EGFR—gallbladder cancer	4.67e-05	0.00085	CbGpPWpGaD
Menadione—MTHFR—Disease—HRAS—gallbladder cancer	4.6e-05	0.000837	CbGpPWpGaD
Menadione—AOX1—Disease—HRAS—gallbladder cancer	4.49e-05	0.000817	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—KRAS—gallbladder cancer	4.41e-05	0.000803	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ERBB2—gallbladder cancer	3.98e-05	0.000724	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HRAS—gallbladder cancer	3.75e-05	0.000683	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NRAS—gallbladder cancer	3.03e-05	0.000551	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EGFR—gallbladder cancer	2.76e-05	0.000502	CbGpPWpGaD
Menadione—F2—Signaling Pathways—KRAS—gallbladder cancer	2.61e-05	0.000474	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TP53—gallbladder cancer	2.32e-05	0.000422	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HRAS—gallbladder cancer	2.22e-05	0.000403	CbGpPWpGaD
